Merck & Co Inc

iCapital’s Anastasia Amoroso Predicts S&P 500 to Reach 5,500 by Year’s End

by
iCapital’s Anastasia Amoroso Predicts S&P 500 to Reach 5,500 by Year’s End

Google New Website Article The S&P 500 Could Reach 5,500 by Year’s End, Expert Says iCapital’s Anastasia Amoroso sees S&P 500 ending at 5,500 this year iCapital chief investment strategist Anastasia Amoroso believes that there’s a good chance the S&P 500 could rise to 5,500 by year’s end. This target would mark an 8% increase … Read more

How the High Cost of Gene Therapies for Sickle Cell Patients Raises Access Concerns

by
How the High Cost of Gene Therapies for Sickle Cell Patients Raises Access Concerns

Highest-ranking article on Sickle Cell Gene Therapies The Challenges and Benefits of Sickle Cell Gene Therapies The Impact of Sickle Cell Disease on Patients and Their Treatment Options The crippling episodes of pain from the genetic blood disorder make life unpredictable for patients like Michael Goodwin. Sickle cell has forced him to leave his job … Read more